PX1 Research provides laboratory investigators and academic institutions with analytical-grade Semax manufactured in domestic USA facilities. Each lot undergoes rigorous third-party testing via RP-HPLC and LC-MS to verify identity, purity, and endotoxin compliance for exacting in vitro and preclinical research applications.
PX1 Research provides laboratory investigators and academic institutions with analytical-grade Semax manufactured in domestic USA facilities. Each lot undergoes rigorous third-party testing via RP-HPLC and LC-MS to verify identity, purity, and endotoxin compliance for exacting in vitro and preclinical research applications.
To buy Semax in the USA for qualified laboratory research, investigators require domestic suppliers capable of providing fully traceable, high-purity synthetic peptides accompanied by independent analytical validation. PX1 Research manufactures and distributes reference-grade Semax synthesized in US-based GMP-compliant facilities, offering verified purity exceeding 99% alongside lot-specific certificates of analysis.
Navigating the domestic market for synthetic neuropeptides demands meticulous oversight regarding chemical identity and purity standards. Many overseas suppliers distribute unverified batches that suffer from variable peptide content, trifluoroacetic acid (TFA) contamination, or unquantified endotoxins. Sourcing through a domestic supplier like PX1 Research eliminates transit delays and supply chain opacity, ensuring that research laboratories receive stable Semax research peptides backed by ISO 17025 accredited laboratory verification.
When acquiring research compounds for biochemical or neurochemical assays, researchers must confirm that the vendor strictly adheres to non-clinical distribution models. Semax supplied by PX1 Research is strictly formatted for in vitro experimentation, cellular assays, and preclinical animal studies, providing researchers with reproducible baseline metrics across all laboratory trials.
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH), specifically the ACTH(4-10) sequence, extended at the C-terminus by a Pro-Gly-Pro tripeptide. Its primary amino acid sequence is Met-Glu-His-Phe-Pro-Gly-Pro (C37H51N9O10S), featuring a molecular mass of approximately 813.93 g/mol. The addition of the C-terminal tripeptide proline-glycine-proline significantly increases the enzymatic resistance of the peptide against endogenous peptidases in biological tissues.
In cell culture models and cell-free degradation assays, standard ACTH fragments rapidly undergo proteolytic cleavage. The structural modification inherent to Semax prolongs its biological half-life in physiological buffered solutions compared to native melanocortin peptide fragments. This structural stability enables extended exposure durations in neural cell assays without immediate degradation into inactive sub-fragments.
Understanding the primary structure of Semax is critical when configuring quantitative analytical protocols such as Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS). Researchers utilizing the PX1 research repository can access structural data and spectral fingerprints to support local methodology development.
Preclinical literature demonstrates that Semax modulates multiple neurochemical pathways without directly binding to traditional neurotransmitter receptors in a classical agonist manner. In rodent models, systemic or intranasal administration of Semax has been shown to rapidly increase the expression of brain-derived neurotrophic factor (BDNF) and its tropomyosin receptor kinase B (TrkB) signaling cascade within the hippocampus and basal forebrain regions.
In vitro neural culture assays indicate that Semax exposure induces microglial activation modulation and exerts neuroprotective effects against glutamate-induced excitotoxicity. Furthermore, expression profiling in animal models suggests that Semax regulates the transcription of neurotrophins, vascular endothelial growth factor (VEGF), and specific inflammatory cytokine gene clusters during acute ischemic events.
Investigators studying neuropeptide research compounds frequently measure the impact of Semax on dopaminergic and serotonergic turnover rates. Research data suggest that Semax enhances dopamine synthesis under acute stress conditions while modulating striatal dopamine receptor activity. These complex signaling pathways render Semax an important probe for investigating neuroplasticity, cerebrovascular regulation, and cellular survival mechanisms.
To properly contextualize laboratory findings, investigators frequently evaluate Semax alongside complementary synthetic neuropeptides in the same functional class. A comparative investigation typically includes Selank, a synthetic heptapeptide derived from immunomodulatory tuftsin, and modified derivatives such as N-Acetyl Semax Amidate, which features N-terminal acetylation and C-terminal amidation to further alter enzymatic stability and lipophilicity.
While Semax predominantly activates BDNF/TrkB expression and cerebrovascular gene cascades in preclinical stroke models, Selank exhibits pronounced interaction with the GABAergic neurotransmitter system and interleukin-6 expression in murine stress assays. Conversely, N-Acetyl Semax Amidate demonstrates increased metabolic resistance in mammalian plasma assays due to capped N- and C-termini, resulting in prolonged baseline exposure curves in comparative kinetic studies.
Selecting the appropriate comparative agent depends on the specific hypothesis under evaluation. Researchers establishing broader experimental paradigms can review our complete catalog of research peptides to identify structural analogs, sequence variations, and secondary reference standards for comparative trial designs.
Reliable preclinical research depends entirely on the analytical purity and consistency of the starting material. At PX1 Research, every production batch of Semax undergoes stringent analytical verification, beginning with RP-HPLC to establish chromatographic purity. Chromatograms must demonstrate a primary peak area corresponding to greater than 99.0% total purity, ensuring the absence of deletion sequences or truncated synthesis byproducts.
Identity verification is performed using Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF), confirming the correct monoisotopic mass of the synthetic peptide. Additionally, because bacterial endotoxins can induce confounding microglial activation and cytokine release in cell cultures, PX1 Research subjects all batches to Chromogenic Recombinant Factor C (rFC) or LAL endotoxin testing, enforcing a strict limit of <0.01 EU/mg.
Each shipment includes a downloadable, lot-specific Certificate of Analysis (COA) generated by an independent ISO 17025 accredited laboratory. Investigators looking into detailed Semax preclinical research protocols can cross-reference batch numbers on our portal to review raw analytical spectra prior to initiating experimental procedures.
Semax is supplied as a sterile, lyophilized (freeze-dried) powder packaged in sealed glass vials under inert gas to prevent oxidation and moisture absorption. Upon arrival at the laboratory, un-reconstituted lyophilized vials should be stored in a dedicated freezer at -20°C or -80°C for long-term stability, protected from direct light exposure.
For reconstitution in experimental protocols, researchers should use sterile Bacteriostatic Water (0.9% Benzyl Alcohol) or sterile Phosphate-Buffered Saline (PBS, pH 7.4), depending on the requirements of the downstream assay. Reconstitution must be performed under a laminar flow hood using aseptic techniques. Gentle swirling of the vial is recommended; aggressive vortexing or mechanical shaking can induce shear forces that degrade the tertiary peptide structure.
Once reconstituted into solution, Semax aliquots should be maintained at 2°C to 8°C and evaluated within short experimental windows, or frozen into single-use sub-aliquots at -80°C to avoid repeated freeze-thaw cycles. Comprehensive handling parameters are available in our dedicated peptide reconstitution guidelines.
Understanding the chemical stability profile of Semax in aqueous media is essential for designing valid long-term cellular exposure experiments. In neutral pH buffer solutions at 37°C, the native ACTH(4-10) sequence degrades rapidly within hours due to endopeptidase cleavage. The structural Pro-Gly-Pro tail of Semax significantly delays this hydrolysis, extending stability in physiological media to several days depending on enzymatic activity.
Experimental variables such as temperature, pH shifts, and exposure to metals or atmospheric oxygen can accelerate peptide degradation via methionine oxidation or deamidation of glutamate residues. Maintaining low storage temperatures and utilizing chelating agents or antioxidants when formulating culture media helps preserve the integrity of the primary peptide chain.
Systematic stability monitoring via analytical RP-HPLC at designated assay intervals allows research teams to verify that active peptide concentration remains constant throughout multi-day tissue culture or organoid studies.
Securing synthetic peptides from domestic US facilities provides distinct procedural advantages over international procurement channels. US-based synthesis ensures strict adherence to standard operating procedures governed by Good Manufacturing Practice (GMP) guidelines, minimizing batch-to-batch variation and eliminating risks associated with international customs seizures or temperature excursions during prolonged ocean or air transit.
PX1 Research operates fulfillment hubs located strategically in California and Arizona, enabling rapid, climate-controlled shipping across the United States. All orders placed Monday through Friday before cut-off times are dispatched same-day, ensuring that lyophilized materials arrive at academic and commercial laboratories without compromising chemical stability.
For high-volume laboratories, government research institutions, and core facility managers requiring multi-gram synthesis or customized batch sizes, PX1 Research maintains dedicated infrastructure for bulk laboratory accounts, supplying custom packaging and dedicated analytical support.
What is Semax designated for in research settings?
Semax is supplied exclusively as a research-grade compound intended for in vitro cellular assays, neurochemical profiling, and preclinical animal research. It is strictly not for human consumption, medical, or clinical use.
How is the purity of Semax verified by PX1 Research?
Every lot of Semax undergoes independent third-party testing at an ISO 17025 accredited laboratory using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm purity >99% and Mass Spectrometry (LC-MS) to verify correct molecular weight.
What solvent is recommended for reconstituting Semax in the lab?
Depending on assay requirements, sterile Bacteriostatic Water or sterile Phosphate-Buffered Saline (PBS, pH 7.4) is typically used for reconstitution under aseptic conditions in a laminar flow hood.
What are the recommended storage temperatures for lyophilized Semax?
Lyophilized Semax should be stored at -20°C or -80°C upon receipt to maintain long-term chemical stability. Reconstituted solutions should be kept at 2°C–8°C for short-term use or aliquoted and stored at -80°C.
How does Semax structurally compare to Selank?
Semax is an heptapeptide derivative of an ACTH(4-10) fragment extended with a Pro-Gly-Pro sequence, whereas Selank is an heptapeptide derived from the immunomodulatory peptide tuftsin. They target distinct neurochemical pathways in preclinical literature.
What endotoxin limits apply to PX1 Research Semax batches?
PX1 Research enforces strict endotoxin screening via rFC or LAL assays, ensuring all Semax lots contain <0.01 EU/mg to prevent confounding cytokine responses in sensitive cellular and tissue assays.
Where does PX1 Research ship Semax from within the USA?
PX1 Research ships directly from fulfillment facilities located in California and Arizona, offering same-day dispatch for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.